The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after administration of single oral doses of 60 to 360 mg in an open-label, five-way crossover study.
The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after oral administration.